SCHEMBL300666

SCHEMBL300666

O=C1N=Nc2cccnc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 3/20 0.46
NSD2 O96028 3/20 0.46
PAX8 Q06710 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
ABL1 P00519 1/20 0.46
PLCG1 P19174 1/20 0.46
CES1 P23141 1/20 0.46
RIN1 Q13671 1/20 0.46
MEN1 O00255 1/20 0.46
THRB P10828 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 1/20 0.46
S100A4 P26447 6/20 0.42
CDC25B P30305 3/20 0.42
PTPRC P08575 2/20 0.42
CTSL P07711 1/20 0.42
CTSS P25774 1/20 0.42
PTPN13 Q12923 1/20 0.42
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388585 0.87 TDP2 (0.48) TDP2NSD2PAX8TDP1ABL1
Benzoic Acid SCHEMBL1879517 0.84 NAPRT (0.45) TDP1CES1MEN1BLMKMT2A
Acetic Acid SCHEMBL9604110 0.78 TDP1 (0.42) TDP2NSD2PAX8TDP1ABL1
SCHEMBL2967094 0.77 TDP2 (0.58) TDP2NSD2PAX8TDP1ABL1
SCHEMBL32689420 0.76 TDP1 (0.39) TDP2NSD2PAX8TDP1ABL1
SCHEMBL32689421 0.74 TDP1 (0.38) TDP2NSD2PAX8TDP1ABL1
SCHEMBL1895059 0.73 TDP1 (0.37) TDP2NSD2PAX8TDP1ABL1
SCHEMBL31288011 0.73 TDP1 (0.37) TDP2NSD2PAX8TDP1ABL1
SCHEMBL2961522 0.72 ALDH1A1 (0.39) TDP2NSD2PAX8TDP1ABL1
SCHEMBL16115792 0.71 ALDH1A1 (0.39) TDP2NSD2PAX8TDP1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 812 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111377915-B Pyrazolo-pyridone compound crystal form D 鲁南制药集团股份有限公司 2023-10-24 CN claimed
CN-113710661-A Compounds and methods for treating cancer 上海睿跃生物科技有限公司 2021-11-26 CN claimed
CN-110467601-B Pyrazole bipyridyl ketone compound, intermediate, preparation method and application thereof 杭州市西溪医院 2021-07-02 CN claimed
WO-2020200291-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2020-10-08 WO claimed
CN-111377915-A Pyrazolo-pyridone compound crystal form D 山东新时代药业有限公司 2020-07-07 CN claimed
EP-1702013-B1 INK AND INK SET FOR INKJET RECORDING FUJIFILM CORP (JP) 2014-09-10 EP claimed
US-7276524-B2 Pyridyl alkane acid amides as cytostatics and immunosuppressives ASTELLAS DEUTSCHLAND GMBH (DE) 2007-10-02 US claimed
US-20070219197-A1 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives ASTELLAS PHARMA GMBH (DE) 2007-09-20 US claimed
US-20070142377-A1 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives BIEDERMANN ELFI 2007-06-21 US claimed
EP-1380585-B1 Pyrazolopyridinone as intermediate PFIZER PROD INC (US) 2004-11-10 EP claimed
US-5665528-A INDOLE DERIVATIVE DYES FUJI PHOTO FILM CO., LTD. (JP) 1997-09-09 US claimed
EP-0775938-A1 Combination of yellow filter dye and 4-equivalent pyrazolone magenta coupler EASTMAN KODAK COMPANY (US) 1997-05-28 EP claimed
US-5609999-A INDOLE DYE; STORAGE STABILITY, COLOR REPRODUCIBILITY, SHARPNESS FUJI PHOTO FILM CO., LTD. (JP) 1997-03-11 US claimed
EP-0430186-B1 Silver halide photographic light-sensitive materials FUJI PHOTO FILM CO LTD (JP) 1995-11-22 EP claimed
US-5459026-A N-phosphonoalkylindole derivatives FUJI PHOTO FILM CO., LTD. (JP) 1995-10-17 US claimed
US-5272050-A Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1993-12-21 US claimed
US-5213957-A Oxonol dye with carboxy or sulfonamide group and indale ring FUJI PHOTO FILM CO., LTD. (JP) 1993-05-25 US claimed
EP-0292825-B1 REACTIVE DYES BAYER AG (DE) 1991-08-07 EP claimed
EP-0430186-A1 Silver halide photographic light-sensitive materials FUJI PHOTO FILM CO., LTD. (JP) 1991-06-05 EP claimed
EP-0292825-A2 Reactive dyes BAYER AG (DE) 1988-11-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219197-A1 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives NFATC1, PDCD1, ACIN1 TDP2 2335/4885NSD2 3557/4885PAX8 2219/4885
US-20070142377-A1 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives ALK, TYMP, PDCD1 TDP2 2723/4885NSD2 3428/4885PAX8 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.